Fig.1
From: Global use of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes. Results from DISCOVER

Use of SGLT2 inhibitors and GLP-1 receptor agonists by country. A Grouped by global region; B Ordered by gross national income per capita